(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the Euronext session.

The three biggest winners today are METABOLIC EXPLORER, LAVIDE HOLDING, and ERYTECH PHARMA.

The three biggest losers today are DLTX, GENEURO, and MEDIA 6.

Winners today

1. METABOLIC EXPLORER (METEX.PA) – 20.86%

METabolic EXplorer S.A., a biological chemistry company, engages in the development and industrialization of industrial fermentation processes as alternatives to petrochemical processes worldwide. The company also offers propanediol, butyric acid, butyric acid, glycolic acid, amino acid, and L-Valine. Its products are used in the formulation of cosmetics, textiles, polymer, animal nutrition, and health products or as intermediates for the synthesis of biomaterials. The company was incorporated in 1999 and is based in Saint-Beauzire, France.

CAC 40 ended the session with METABOLIC EXPLORER rising 20.86% to €1.37 on Monday while CAC 40 rose 1.51% to €7,295.55.

Earnings Per Share

As for profitability, METABOLIC EXPLORER has a trailing twelve months EPS of €-0.81.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -9.9%.

Moving Average

METABOLIC EXPLORER’s worth is higher than its 50-day moving average of €1.30 and way below its 200-day moving average of €2.10.

Revenue Growth

Year-on-year quarterly revenue growth grew by 249.9%, now sitting on 264.36M for the twelve trailing months.

Volatility

METABOLIC EXPLORER’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.75%, a negative 0.56%, and a positive 2.33%.

METABOLIC EXPLORER’s highest amplitude of average volatility was 1.46% (last week), 1.47% (last month), and 2.33% (last quarter).

More news about METABOLIC EXPLORER.

2. LAVIDE HOLDING (LVIDE.AS) – 15.45%

Lavide Holding N.V. does not have significant operations. Previously, it was engaged in the provision of integrated information technology solutions for medium to large-sized companies and organizations. The company was formerly known as Qurius N.V. and changed its name to Lavide Holding N.V. in July 2013. Lavide Holding N.V. was incorporated in 1998 and is based in Sluis, the Netherlands.

AEX-Index ended the session with LAVIDE HOLDING jumping 15.45% to €0.19 on Monday, after five sequential sessions in a row of losses. AEX-Index jumped 1.42% to €756.99, after five sequential sessions in a row of losses, on what was an all-around up trend exchanging session today.

Earnings Per Share

As for profitability, LAVIDE HOLDING has a trailing twelve months EPS of €-0.025.

More news about LAVIDE HOLDING.

3. ERYTECH PHARMA (ERYP.PA) – 15.36%

ERYTECH Pharma S.A., a clinical-stage biopharmaceutical company, develops red blood cell-based therapeutics for cancer and orphan diseases in France and the United States. Its lead product candidate is eryaspase, which is in Phase 3 clinical development for the treatment of second-line pancreatic cancer, and in Phase 2 stage for the treatment of triple-negative breast cancer and second-line acute lymphoblastic leukemia patients. The company also engages in developing erymethionase, a preclinical product candidate that consists of methionine-?-lyase in red blood cells to target methionine cancers. The company was incorporated in 2004 and is headquartered in Lyon, France.

CAC 40 ended the session with ERYTECH PHARMA jumping 15.36% to €0.89 on Monday, after four successive sessions in a row of losses. CAC 40 jumped 1.51% to €7,295.55, following the last session’s downward trend on what was an all-around bullish trend exchanging session today.

Earnings Per Share

As for profitability, ERYTECH PHARMA has a trailing twelve months EPS of €-3.99.

Revenue Growth

Year-on-year quarterly revenue growth declined by 58.5%, now sitting on 2.2M for the twelve trailing months.

Earnings Before Interest, Taxes, Depreciation, and Amortization

ERYTECH PHARMA’s EBITDA is 7.45.

Volatility

ERYTECH PHARMA’s last week, last month’s, and last quarter’s current intraday variation average was a negative 4.35%, a positive 1.33%, and a positive 5.78%.

ERYTECH PHARMA’s highest amplitude of average volatility was 4.35% (last week), 7.02% (last month), and 5.78% (last quarter).

More news about ERYTECH PHARMA.

4. AVENIR TELECOM (AVT.PA) – 13.24%

Avenir Telecom S.A. retails and distributes mobiles, smartphones, and accessories. The company offers chargers, cables, protection screens and cases, memory, and USB products, multiports, HUBS, and other products under the Energizer brand. It also designs and manufactures accessories under Oxo brand. The company sells its products in 55 countries. Avenir Telecom S.A. was founded in 1989 and is based in Marseille, France.

CAC 40 ended the session with AVENIR TELECOM rising 13.24% to €0.24 on Monday while CAC 40 jumped 1.51% to €7,295.55.

Earnings Per Share

As for profitability, AVENIR TELECOM has a trailing twelve months EPS of €-0.023.

Volatility

AVENIR TELECOM’s last week, last month’s, and last quarter’s current intraday variation average was 12.98%, 5.03%, and 8.31%.

AVENIR TELECOM’s highest amplitude of average volatility was 15.41% (last week), 9.50% (last month), and 8.31% (last quarter).

More news about AVENIR TELECOM.

5. FONCIERE EURIS (EURS.PA) – 10.87%

Foncière Euris SA distributes food and specialized products in France and internationally. The company also owns real estate assets, including shopping centers; and manages commercial real estate properties and private equity portfolio. The company was incorporated in 1970 and is based in Paris, France. Foncière Euris SA operates as a subsidiary of Finatis Société Anonyme.

CAC 40 ended the session with FONCIERE EURIS jumping 10.87% to €5.10 on Monday while CAC 40 jumped 1.51% to €7,295.55.

Earnings Per Share

As for profitability, FONCIERE EURIS has a trailing twelve months EPS of €-49.02.

Volume

Today’s last reported volume for FONCIERE EURIS is 1 which is 99.63% below its average volume of 275.

More news about FONCIERE EURIS.

6. FIN.OUEST AFRICAIN (FOAF.PA) – 9.77%

Fin.Ouest Africain provides various financial services. It offers car, personal, business risk, transportation, and other property and casualty insurance products; and life insurance products for individuals, private and public companies, and organizations. It also invests in bonds and shares in listed and unlisted companies; and provides wealth management services, including building and managing real estate assets. The company was founded in 1951 and is based in Dakar, Senegal.

CAC 40 ended the session with FIN.OUEST AFRICAIN jumping 9.77% to €29.20 on Monday, after five sequential sessions in a row of gains. CAC 40 jumped 1.51% to €7,295.55, following the last session’s downward trend on what was an all-around up trend trading session today.

More news about FIN.OUEST AFRICAIN.

7. MEMSCAP REGPT (MEMS.PA) – 8.66%

MEMSCAP, S.A. provides micro-electro-mechanical systems (MEMS) based solutions for aerospace and defense, optical communications, medical and biomedical, and IT/consumer markets worldwide. The company offers pressure sensors, pressure transducers, and pressure switches for various applications, such as air data computers, cabin pressure, engine control, altimeters, barometers, cockpit instruments, and air data test sets. It also provides gold coated and titanium-based pressure transducers, plastic domes, line-sets, and related accessories; and magnetic switches/relays, as well as supplies implantable pressure sensors for spinal pressure monitoring, abdominal aortic aneurism, etc. In addition, the company supplies optical MEMS chips for variable optical attenuators in optical telecommunication markets; and provides the multi-user MEMS processes (MUMPs) comprising PolyMUMPs, SOIMUMPs, and PiezoMUMPs, as well as MUMPs-PLUS and post processing services. Further, it offers custom products, including wafers, MEMS dies, and wafer level packaged devices; and manufacturing services, as well as prototyping services. The company sells its products and services to Fortune 500 companies, high-technology industries, research institutes, and universities. MEMSCAP, S.A. was founded in 1997 and is headquartered in Crolles, France.

CAC 40 ended the session with MEMSCAP REGPT rising 8.66% to €1.95 on Monday, following the last session’s downward trend. CAC 40 rose 1.51% to €7,295.55, following the last session’s downward trend on what was an all-around up trend exchanging session today.

Volume

Today’s last reported volume for MEMSCAP REGPT is 21416 which is 15.29% above its average volume of 18575.

Revenue Growth

Year-on-year quarterly revenue growth declined by 13.3%, now sitting on 9.77M for the twelve trailing months.

Moving Average

MEMSCAP REGPT’s value is way higher than its 50-day moving average of €1.54 and way above its 200-day moving average of €1.22.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, MEMSCAP REGPT’s stock is considered to be oversold (<=20).

More news about MEMSCAP REGPT.

8. GEOJUNXION (GOJXN.AS) – 8.19%

GeoJunxion N.V. manufactures and supplies digital maps, premium location content, and location intelligence services worldwide. The company provides location aware content products, including Digital Maps for use in routing, planning, and display services; Geo Location application programming interface (API) that addresses geocoding and time zones covering Europe and North America; and Geo Planning API, which provides time and distance matrices for logistics and resource planning applications, as well as premium location content products, such as Safety Alert Zone that concentrates on road safety by alerting mobility users; Eco Alert Zones, which includes dataset of regulated congestion, emission and restricted traffic zones for use in routing, planning, fleet management, display, real estate applications, and other sectors; and Health Alert Zones that contains COVID-19 related information. It also offers location intelligence services, which includes search and evaluation of location enabled content to enhance existing maps and/or routing applications; creating bespoke datasets; and producing outdoor venue plans for use in events, travel and tourism, real estate applications, last mile navigation and delivery, retail and distribution, and smart city applications, as well as operates GeoAlertsLive application. The company was formerly known as AND International Publishers N.V. GeoJunxion N.V. was founded in 1984 and is headquartered in Capelle aan den IJssel, the Netherlands.

AEX-Index ended the session with GEOJUNXION jumping 8.19% to €1.59 on Monday while AEX-Index jumped 1.42% to €756.99.

Earnings Per Share

As for profitability, GEOJUNXION has a trailing twelve months EPS of €-0.295.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -0.3%.

Volume

Today’s last reported volume for GEOJUNXION is 61 which is 97.93% below its average volume of 2958.

More news about GEOJUNXION.

9. MAROC TELECOM (IAM.PA) – 8.08%

Itissalat Al-Maghrib (IAM) S.A., together with its subsidiaries, provides various telecommunication services in Morocco and internationally. It offers mobile, fixed-line, Internet, and fixed-line broadband telecommunication services, as well as sells mobile terminals, broadband equipment, and connected objects and accessories. The company was founded in 1998 and is based in Rabat, Morocco. As of October 28, 2021, Itissalat Al-Maghrib (IAM) S.A. operates as subsidiary of Emirates Telecommunications Group Company PJSC.

CAC 40 ended the session with MAROC TELECOM jumping 8.08% to €9.36 on Monday while CAC 40 rose 1.51% to €7,295.55.

Volatility

MAROC TELECOM’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.70%, a negative 0.06%, and a positive 1.73%.

MAROC TELECOM’s highest amplitude of average volatility was 1.98% (last week), 1.34% (last month), and 1.73% (last quarter).

Volume

Today’s last reported volume for MAROC TELECOM is 371 which is 41.48% below its average volume of 634.

More news about MAROC TELECOM.

10. DBV TECHNOLOGIES (DBV.PA) – 7.06%

DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents, and adults. The milk-induced company is also developing Viaskin Milk that is in Phase I/II clinical trial for the treatment of Immunoglobulin E (IgE) mediated cow's milk protein allergy (CMPA); Viaskin Egg, a pre-clinical stage product for the treatment of hen's egg allergy; and booster vaccine for Bordetella pertussis. Its other earlier stage research programs include a vaccine for the respiratory syncytial virus, as well as treatments for Crohn's disease, celiac disease, and type I diabetes. The company has a collaboration with Nestlé Health Science to develop MAG1C, a ready-to-use atopy patch test for the diagnosis of non-IgE mediated CMPA in infants and toddlers. DBV Technologies S.A. was incorporated in 2002 and is headquartered in Montrouge, France.

CAC 40 ended the session with DBV TECHNOLOGIES rising 7.06% to €2.82 on Monday while CAC 40 jumped 1.51% to €7,295.55.

Earnings Per Share

As for profitability, DBV TECHNOLOGIES has a trailing twelve months EPS of €-0.98.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -42.99%.

More news about DBV TECHNOLOGIES.

Losers Today

1. DLTX (DLTX.OL) – -17.86%

DLT ASA, a technology company, invests in distributed ledger technology and blockchain sectors. It engages in the provision of commercial business, physical infrastructure, and software services. The company is based in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with DLTX falling 17.86% to €3.45 on Monday while Oslo Børs Benchmark Index_GI rose 0.86% to €1,237.19.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, DLTX’s stock is considered to be oversold (<=20).

More news about DLTX.

2. GENEURO (GNRO.PA) – -11.43%

GeNeuro SA, a clinical-stage biopharmaceutical company, develops drugs for the treatment of neurodegenerative and autoimmune diseases. The company's lead therapeutic candidate is temelimab, a monoclonal antibody, which has completed Phase IIb clinical trial for multiple sclerosis; and is in Phase IIa to treat type 1 diabetes, as well as is in Phase I for the treatment of chronic inflammatory demyelinating polyneuropathy. It has cooperative research and development agreements with The National Institute of Neurological Disorders and Stroke to develop novel therapeutic antibodies for the treatment of amyotrophic lateral sclerosis; and Academic centers to develop inflammatory psychosis, as well as a research collaboration agreement with International Center for Infectiology Research; and with Northwestern University for human endogenous retrovirus W envelope protein (HERV-W ENV) in long-haul COVID patients. The company was incorporated in 2006 and is headquartered in Plan-les-Ouates, Switzerland.

CAC 40 ended the session with GENEURO dropping 11.43% to €2.48 on Monday, following the last session’s upward trend. CAC 40 jumped 1.51% to €7,295.55, following the last session’s downward trend on what was an all-around positive trend exchanging session today.

Earnings Per Share

As for profitability, GENEURO has a trailing twelve months EPS of €-0.45.

Volatility

GENEURO’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.24%, a positive 4.32%, and a positive 4.04%.

GENEURO’s highest amplitude of average volatility was 1.20% (last week), 6.34% (last month), and 4.04% (last quarter).

Volume

Today’s last reported volume for GENEURO is 9295 which is 33.77% above its average volume of 6948.

More news about GENEURO.

3. MEDIA 6 (EDI.PA) – -9.95%

Groupe MEDIA 6, a point-of-purchase (POP) advertising company, provides multi-material solutions in France and internationally. The company offers hydro-alcoholic gel dispensing column with PMR access options, counter displays, plexiglass protective barriers, protective visors, and floor markings; merchandising management services; point-of-purchase marketing; installs furniture, shop windows, podiums, and communication materials; and processes cardboard, wood, metal, and plastic products. It also provides experiential marketing, POP displays, shop fixtures, shop fittings, pharmacy fittings, trade marketing, and POP display for coloration, as well as operates art workshop. In addition, it offers various tools for the customization of sales accessories, product racks, bag and shoe doors, presentation trays, articulated hands, wooden feet and head, and busts and displays for shops. The company was founded in 1977 and is based in Tremblay-en-France, France. Groupe MEDIA 6 is a subsidiary of VASCO SARL.

CAC 40 ended the session with MEDIA 6 dropping 9.95% to €8.60 on Monday, after five sequential sessions in a row of losses. CAC 40 jumped 1.51% to €7,295.55, following the last session’s downward trend on what was an all-around bullish trend exchanging session today.

Earnings Per Share

As for profitability, MEDIA 6 has a trailing twelve months EPS of €-1.27.

More news about MEDIA 6.

4. POSTNL (PNL.AS) – -7.7%

PostNL N.V. provides postal and logistics services to businesses and consumers in the Netherlands, rest of Europe, and internationally. The company operates in two segments, Parcels, Mail in the Netherlands; and PostNL Other. It collects, sorts, transports, and delivers letters and parcels; and offers data and document management, direct marketing, and fulfillment services, as well as cross-border mail solutions. The company was formerly known as TNT N.V. and changed its name to PostNL N.V. in May 2011. PostNL N.V. is headquartered in the Hague, the Netherlands.

AEX-Index ended the session with POSTNL falling 7.7% to €1.68 on Monday while AEX-Index jumped 1.42% to €756.99.

Earnings Per Share

As for profitability, POSTNL has a trailing twelve months EPS of €0.43.

PE Ratio

POSTNL has a trailing twelve months price to earnings ratio of 3.9. Meaning, the purchaser of the share is investing €3.9 for every euro of annual earnings.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, POSTNL’s stock is considered to be overbought (>=80).

Volume

Today’s last reported volume for POSTNL is 9498430 which is 354.07% above its average volume of 2091840.

Volatility

POSTNL’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.08%, a negative 0.29%, and a positive 1.70%.

POSTNL’s highest amplitude of average volatility was 1.08% (last week), 1.34% (last month), and 1.70% (last quarter).

More news about POSTNL.

5. MKB Nedsense (NEDSE.AS) – -7.55%

MKB Nedsense N.V. engages in the finance and lending of money to natural persons and legal entities. It also provides guarantees and/or other securities towards third parties for its obligations and/or for obligations for companies in the investment portfolio. The company was formerly known as Nedsense Enterprises N.V. MKB Nedsense N.V. was founded in 1999 and is based in Bussum, the Netherlands.

AEX-Index ended the session with MKB Nedsense dropping 7.55% to €0.13 on Monday, following the last session’s upward trend. AEX-Index jumped 1.42% to €756.99, after five consecutive sessions in a row of losses, on what was an all-around bullish trend trading session today.

Earnings Per Share

As for profitability, MKB Nedsense has a trailing twelve months EPS of €0.005.

PE Ratio

MKB Nedsense has a trailing twelve months price to earnings ratio of 25.7. Meaning, the purchaser of the share is investing €25.7 for every euro of annual earnings.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, MKB Nedsense’s stock is considered to be oversold (<=20).

More news about MKB Nedsense.

6. SES (SESG.PA) – -7.21%

SES S.A. provides satellite and ground infrastructure solutions worldwide. The company offers data connectivity services through its MEO and GEO satellite communication systems for aviation, maritime, cruise, energy, government, and telco and MNO industries. It also provides video services, including direct to home broadcast, occasional use, IP delivery, cable distribution, channel management, over the top (OTT), satellite distribution, hybrid TV platform, online video platform, content aggregation, SES 360, audience measurement and ad insertion, subscriber management, content distribution, production, value added, and real time booking services for broadcasters, platform operators, and sports organizations. The company was formerly known as SES Global S.A. and changed its name to SES S.A. in 2006. SES S.A. was founded in 1985 and is headquartered in Betzdorf, Luxembourg.

CAC 40 ended the session with SES falling 7.21% to €6.72 on Monday, following the last session’s downward trend. CAC 40 jumped 1.51% to €7,295.55, following the last session’s downward trend on what was an all-around up trend exchanging session today.

Earnings Per Share

As for profitability, SES has a trailing twelve months EPS of €-0.3.

More news about SES.

7. SODITECH (SEC.PA) – -6.94%

Soditech SA engages in the integration of mechanical, thermal, and electronic sub-assemblies in space, research, and defense fields in France. It designs structural sub-assemblies and integrates optical and thermal equipment, such as OSRs, SSMs, heaters, and heat pipes; designs and manufactures multi-layer insulation products; and designs, manufactures, and tests space harnesses on instruments or platforms. The company also provides calculation services, such as static, dynamic, thermal, and thermoelastic; designs assembly tools; and designs and produces super insulating multi-layer mattresses for ultra-vacuum areas. In addition, it develops, qualifies, manufactures, and tests embedded cabinets; and designs, assembles, and tests racks and test equipment racks. The company was formerly known as Soditech Ingenierie SA. Soditech SA was founded in 1990 and is headquartered in Aix-en-Provence, France.

CAC 40 ended the session with SODITECH falling 6.94% to €1.61 on Monday, following the last session’s upward trend. CAC 40 rose 1.51% to €7,295.55, following the last session’s downward trend on what was an all-around positive trend exchanging session today.

Earnings Per Share

As for profitability, SODITECH has a trailing twelve months EPS of €0.023.

PE Ratio

SODITECH has a trailing twelve months price to earnings ratio of 70. Meaning, the purchaser of the share is investing €70 for every euro of annual earnings.

Volume

Today’s last reported volume for SODITECH is 1 which is 99.9% below its average volume of 1007.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, SODITECH’s stock is considered to be oversold (<=20).

Volatility

SODITECH’s last week, last month’s, and last quarter’s current intraday variation average was 5.11%, 1.04%, and 4.87%.

SODITECH’s highest amplitude of average volatility was 6.28% (last week), 6.71% (last month), and 4.87% (last quarter).

More news about SODITECH.

8. VALUE8 CUM PREF (PREVA.AS) – -5.66%

Value8 N.V. is a private equity firm specializing in growth capital investments in small and medium-sized companies. The firm primarily invests in the food, healthcare, business and financial services, energy, safety and security, water and environment, leisure, luxury products and internet sectors. It typically invests in Western Europe, primarily in the Netherlands, Belgium and France. The firm considers investments in companies with an enterprise value between €5 million ($6.96 million) and €150 million ($208.87 million). The firm prefers to take a seat on the board of directors and seeks to exit the investment through a public listing. Value8 NV was founded in 2008 and is headquartered in Bussum, the Netherlands.

AEX-Index ended the session with VALUE8 CUM PREF falling 5.66% to €5.00 on Monday, following the last session’s upward trend. AEX-Index jumped 1.42% to €756.99, after five sequential sessions in a row of losses, on what was an all-around positive trend trading session today.

Earnings Per Share

As for profitability, VALUE8 CUM PREF has a trailing twelve months EPS of €0.878.

PE Ratio

VALUE8 CUM PREF has a trailing twelve months price to earnings ratio of 5.69. Meaning, the purchaser of the share is investing €5.69 for every euro of annual earnings.

Volatility

VALUE8 CUM PREF’s last week, last month’s, and last quarter’s current intraday variation average was 6.00%, 1.60%, and 3.20%.

VALUE8 CUM PREF’s highest amplitude of average volatility was 6.00% (last week), 4.10% (last month), and 3.20% (last quarter).

More news about VALUE8 CUM PREF.

9. OREGE (OREGE.PA) – -5.62%

Orege Société Anonyme designs, develops, operates, manufactures, and markets municipal and industrial sludge, and effluents treatment solutions in France, the United States, Japan, Germany, and the United Kingdom. The company offers SLG solution for conditioning, treating, and recovering municipal and industrial sludge; SLG-F, a combination of SLG conditioning solution; and Flosep for sludge separation and thickening tool. It also provides after-sales, installation and commissioning, operator training, warranty extensions, maintenance, and process line optimization services. The company was incorporated in 2005 and is headquartered in Voisins-Le-Bretonneux, France. Orege Société Anonyme is a subsidiary of Eren Groupe SA.

CAC 40 ended the session with OREGE dropping 5.62% to €0.42 on Monday while CAC 40 rose 1.51% to €7,295.55.

Earnings Per Share

As for profitability, OREGE has a trailing twelve months EPS of €-0.103.

Revenue Growth

Year-on-year quarterly revenue growth grew by 36.5%, now sitting on 2.55M for the twelve trailing months.

Moving Average

OREGE’s value is way below its 50-day moving average of €0.50 and way below its 200-day moving average of €0.61.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, OREGE’s stock is considered to be oversold (<=20).

More news about OREGE.

10. TARGOVAX (TRVX.OL) – -5.03%

Targovax ASA, a clinical stage immuno-oncology company, engages in the development of immune activators to target hard-to-treat solid tumors. Its lead product candidate is ONCOS-102, which is in Phase I/II clinical trials for the treatment of mesothelioma, melanoma, and colorectal cancer. The company is also developing neoantigen vaccines targeting mutant KRAS cancers. In addition, it is developing ONCOS-211 for next generation ONCOS viruses. The company has collaboration agreements with Cancer Research Institute and Ludwig Cancer Research to develop ONCOS-102 for colorectal cancer with peritoneal carcinomatosis; Valo Therapeutics to develop mutant RAS neoantigen coating of ONCOS viruses using PeptiCRAd technology; and Papyrus Therapeutics to develop novel ONCOS viruses with Receptor Tyrosine Kinase inhibitor functionality. Targovax ASA was incorporated in 2010 and is based in Lysaker, Norway.

Oslo Børs Benchmark Index_GI ended the session with TARGOVAX dropping 5.03% to €0.83 on Monday while Oslo Børs Benchmark Index_GI jumped 0.86% to €1,237.19.

Earnings Per Share

As for profitability, TARGOVAX has a trailing twelve months EPS of kr-1.402.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -32.59%.

Volume

Today’s last reported volume for TARGOVAX is 922051 which is 13.95% above its average volume of 809126.

Volatility

TARGOVAX’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.59%, a negative 0.90%, and a positive 2.72%.

TARGOVAX’s highest amplitude of average volatility was 3.81% (last week), 3.68% (last month), and 2.72% (last quarter).

More news about TARGOVAX.

Stay up to date with our winners and losers daily report